The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
Items 501–600 of 1,000
Neurophysiology in psychosis: The quest for disease biomarkers
Wang, B., Zartaloudi, E., Linden, J. F., & Bramon, E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01860-x · Cited by 49
Endophenotypes in the personality disorders
Siever, L. J. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/lsiever · Cited by 47
Phillips, J. M., Ehrlichman, R. S., & Siegel, S. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.003 · Cited by 47
Siegel, S. J., Maxwell, C. R., Majumdar, S., Trief, D., Lerman, C. E., Gur, R. E., Kanes, S., & Liang, Y. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.027 · Cited by 47
Genetic overlap between P300, P50, and duration mismatch negativity
Hall, M., Schulze, K., Bramon, E., Murray, R. M., Sham, P. C., & Rijsdijk, F. V. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30318 · Cited by 47
Mann, C., Croft, R. J., Scholes‐Balog, K. E., Dunne, A., O’Neill, B. V., Leung, S., Copolov, D., Phan, K. L., & Nathan, P. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301556 · Cited by 47
Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence
Turner, J. R., Ray, R., Lee, B., Everett, L. J., Xiang, J. J., Jepson, C., Kaestner, K. H., Lerman, C. E., & Blendy, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.104 · Cited by 49
The Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 47
Biomarkers of bipolar disorder specific or shared with schizophrenia
Bellivier, F. (2013) · Frontiers in Bioscience-Elite · doi:10.2741/e665 · Cited by 46
Experimental modification of P50 suppression
Yee, C. M., & White, P. M. (2001) · Psychophysiology · doi:10.1017/s0048577201981454 · Cited by 46
P50 sensitivity to physical and psychological state influences
White, P. M., & Yee, C. M. (2006) · Psychophysiology · doi:10.1111/j.1469-8986.2006.00408.x · Cited by 46
Luca, V. D., Voineskos, S. H., Wong, G., & Kennedy, J. L. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0458-y · Cited by 46
α7-Nicotinic receptor expression and the anatomical organization of hippocampal interneurons
Adams, C. E., Stitzel, J. A., Collins, A. C., & Freedman, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03115-8 · Cited by 45
Self-citationNicotine Effects on Mismatch Negativity in Nonsmoking Schizophrenic Patients
Inami, R., Kirino, E., Inoue, R., Suzuki, T., & Arai, H. (2007) · Neuropsychobiology · doi:10.1159/000111536 · Cited by 45
Smoking initiation and schizophrenia: a replication study in a Spanish sample
Gurpegui, M., Martínez-Ortega, J. M., Aguilar, M. C., Díaz, F. J., Quintana, H. M., & de León, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.007 · Cited by 45
Mefford, H. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181c175d2 · Cited by 49
Aznavour, N., Watkins, K. C., & Descarries, L. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20501 · Cited by 45
Electrophysiological Endophenotypes for Schizophrenia
Owens, E. M., Bachman, P., Glahn, D. C., & Bearden, C. E. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000110 · Cited by 50
Significant linkage to chromosome 22q for exploratory eye movement dysfunction in schizophrenia
Takahashi, S., Ohtsuki, T., Yu, S., Tanabe, E., Yara, K., Kamioka, M., Matsushima, E., Matsuura, M., Ishikawa, K., Minowa, Y., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10046 · Cited by 44
Knott, V., Fisher, D. J., & Millar, A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.012 · Cited by 44
Redrobe, J. P., Jørgensen, M., Christoffersen, C. T., Montezinho, L. P., Bastlund, J. F., Carnerup, M. A., Bundgaard, C., Lerdrup, L., & Plath, N. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3492-7 · Cited by 44
Millan, M. J., & Brocco, M. (2008) · Therapies · doi:10.2515/therapie:2008041 · Cited by 44
Hall, M., Schulze, K., Sham, P. C., Kalidindi, S., McDonald, C., Bramon, E., Levy, D. L., Murray, R. M., & Rijsdijk, F. V. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30653 · Cited by 44
Does clozapine decrease smoking?
de León, J., Díaz, F. J., Josiassen, R. C., Cooper, T. B., & Simpson, G. M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.031 · Cited by 44
Caffeine Intake in Outpatients With Schizophrenia
Gurpegui, M., Aguilar, M. C., Martínez-Ortega, J. M., Díaz, F. J., & de León, J. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007143 · Cited by 45
P50 sensory gating is related to performance on select tasks of cognitive inhibition
Yadon, C. A., Bugg, J. M., Kisley, M. A., & Davalos, D. B. (2009) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.9.4.448 · Cited by 43
Bodkin, J. A., Coleman, M. J., Godfrey, L., Carvalho, C. M. B., Morgan, C. J., Suckow, R. F., Anderson, T., Öngür, D., Kaufman, M. J., Lewandowski, K. E., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.031 · Cited by 44
Exploratory eye movement dysfunction as a discriminator for schizophrenia
Suzuki, M., Takahashi, S., Matsushima, E., Tsunoda, M., Kurachi, M., Okada, T., Hayashi, T., Ishii, Y., Morita, K., Maeda, H., et al. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0850-7 · Cited by 43
Flomen, R. H., Davies, A. F., Forti, M. D., Cascia, C. L., Ogilvie, C. M., Murray, R. M., & MAKOFF, A. J. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.112 · Cited by 43
Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia
Bolonna, A. A., Kerwin, R. W., Munro, J., Arranz, M. J., & MAKOFF, A. J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00235-2 · Cited by 43
Agulhon, C., Charnay, Y., Vallet, P. G., Bertrand, D., & Malafosse, A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00113-2 · Cited by 43
George, T. P., Verrico, C. D., & Roth, R. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00537-x · Cited by 43
Hallmayer, J. F., Jablensky, A. V., Michie, P. T., Woodbury, M. A., Salmon, B., Combrinck, J. M., Wichmann, H., Rock, D. J., D'Ercole, M., Howell, S., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001273 · Cited by 43
Mechanistic insights into the genetics of affective psychosis from Prader-Willi syndrome
Aman, L. C. S., Manning, K. E., Whittington, J. E., & Holland, A. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30009-9 · Cited by 42
Yang, T., Guo, Y., Papasian, C. J., & Deng, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00009-3 · Cited by 42
Psychological Co-morbidities of Physical Illness
Pagoto, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0029-6 · Cited by 44
Neuropsychiatric dynamics: the study of mental illness using functional magnetic resonance imaging
Callicott, J. H., & Weinberger, D. R. (1999) · European Journal of Radiology · doi:10.1016/s0720-048x(99)00048-0 · Cited by 42
Zhang, X. Y., Cao, L. Y., Song, C., Wu, G. Y., Chen, D. C., Qi, L. Y., Wang, F., Xiu, M. H., Chen, S., Zhang, Y., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1295-4 · Cited by 42
Study of the calcium dynamics of the human α4β2, α3β4 and α1β1γδ nicotinic acetylcholine receptors
Michelmore, S., Croskery, K., Nozulak, J., Hoyer, D., Longato, R., Weber, A., Bouhelal, R., & Feuerbach, D. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0589-z · Cited by 42
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice
Weiss, S., Tzavara, E. T., Davis, R. J., Nomikos, G. G., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.002 · Cited by 44
Waldo, M. C. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00031-6 · Cited by 42
Self-citationSeverance, E. G., Zhang, H., Cruz, Y., Pakhlevaniants, S., Hadley, S. H., Αmin, J., Wecker, L., Reed, C., & Cuevas, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000059 · Cited by 42
Deficits in auditory P50 inhibition in obsessive-compulsive disorder
Hashimoto, T., Shimizu, E., Koike, K., Orita, Y., Suzuki, T., Kanahara, N., Matsuzawa, D., Fukami, G., Miyatake, R., Shinoda, N., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.021 · Cited by 41
Role of the cholinergic system in the pathology and treatment of schizophrenia
Scarr, E., & Dean, B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.73 · Cited by 41
P50 inhibitory sensory gating in schizophrenia: analysis of recent studies
Freedman, R., Olsen-Dufour, A. M., & D, A. O. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.003 · Cited by 45
Self-citationSuppression of P50 evoked potential component, schizotypal beliefs and smoking
Croft, R. J., Dimoska, A., Gonsalvez, C. J., & Clarke, A. R. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.05.009 · Cited by 41
Nicotine: abused substance and therapeutic agent.
Houezec, J. L. (1998) · PubMed Central · Cited by 41
Hypofrontality — a risk-marker related to schizophrenia?
Wuebben, Y., & Winterer, G. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00047-5 · Cited by 41
EEG biomarkers of target engagement, therapeutic effect, and disease process
Featherstone, R. E., McMullen, M. F., Ward, K. R., Bang, J., Xiao, J., & Siegel, S. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12745 · Cited by 40
Schizophrenia and visual backward masking: a general deficit of target enhancement
Herzog, M. H., Roinishvili, M., Chkonia, E. D., & Brand, A. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00254 · Cited by 40
Duffy, Á. M., Zhou, P., Milner, T. A., & Pickel, V. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.024 · Cited by 49
Hansen, H. H., Timmermann, D. B., Peters, D., Walters, C. L., Damaj, M. I., & Mikkelsen, J. D. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21293 · Cited by 40
The Adenosine Antagonist Theophylline Impairs P50 Auditory Sensory Gating in Normal Subjects
Ghisolfi, E. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00337-8 · Cited by 40
Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis
de León, J., Díaz, F. J., Aguilar, M. C., Jurado, D., & Gurpegui, M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.009 · Cited by 40
P50 sensory gating: Impact of high vs. low schizotypal personality and smoking status
Wan, L., Crawford, H. J., & Boutros, N. N. (2005) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.03.024 · Cited by 40
Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Jaco, A. D., Bernardini, L., Rosati, J. D., & Tata, A. M. (2016) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524916666160729111446 · Cited by 40
Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
LLerena, A., de la Rubia, A., Peñas‐Lledó, E., Díaz, F. J., & de León, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00508-x · Cited by 40
Chronic corticosterone treatment alters sensory gating in C3H mice
Stevens, K. E., Bullock, A. E., & Collins, A. C. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00523-8 · Cited by 40
Delayed onset of inhibition of return in schizophrenia
Larrison, A. L., Briand, K. A., & Sereno, A. B. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00298-6 · Cited by 40
Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis?
Shaikh, M., Hall, M., Schulze, K., Dutt, A., Walshe, M., Williams, I. L., Constante, M., Picchioni, M., Toulopoulou, T., Collier, D. A., et al. (2010) · Psychological Medicine · doi:10.1017/s003329170999239x · Cited by 40
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications
Tizabi, Y., Copeland, R., Brus, R., & Kostrzewa, R. M. (1999) · Psychopharmacology · doi:10.1007/s002130051078 · Cited by 39
Auditory inhibitory gating in the amygdala: Single-unit analysis in the behaving rat
Cromwell, H. C., Anstrom, K. K., Azarov, A., & Woodward, D. J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.106 · Cited by 39
Malaspina, D., Brown, A., Goetz, D. M., Alia‐Klein, N., Harkavy‐Friedman, J., Harlap, S., & Fennig, S. (2002) · CNS Spectrums · doi:10.1017/s1092852900022239 · Cited by 39
Adler, L. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00242-6 · Cited by 39
Self-citationHunter, S. K., Kisley, M. A., McCarthy, L., Freedman, R., & Ross, R. G. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq036 · Cited by 38
Self-citationRowe, A. R., Mercer, L., Casetti, V., Sendt, K.-V., Giaroli, G., Shergill, S. S., & Tracy, D. K. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114564096 · Cited by 41
Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia
Bob, P., Vlček, P., & Raboch, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64219 · Cited by 38
Bakanidze, G., Roinishvili, M., Chkonia, E. D., Kitzrow, W., Richter, S., Neumann, K., Herzog, M. H., Brand, A., & Puls, I. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00133 · Cited by 39
Carson, R., Craig, D., Hart, D. J., Todd, S., McGuinness, B., Johnston, J. A., O’Neill, F. A., Ritchie, C. W., & Passmore, A. P. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8048-8 · Cited by 38
de León, J., & Díaz, F. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1122-6 · Cited by 39
Aliyu, M. H., Calkins, M. E., Swanson, C. L., Lyons, P. D., Savage, R. M., May, R., Wiener, H. W., Devlin, B., Nimgaonkar, V. L., Ragland, J. D., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.027 · Cited by 38
Vallés, A. S., & Barrantes, F. J. (2023) · Cells · doi:10.3390/cells12162051 · Cited by 37
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review
Lewis, J. E., Poles, J., Shaw, D. P., Karhu, E., Khan, S. A., Lyons, A. E., Sacco, S. B., & McDaniel, H. R. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202104.014 · Cited by 37
Platelet Serotonergic Markers as Endophenotypes for Obsessive-Compulsive Disorder
Delorme, R., Betancur, C., Callebert, J., Chabane, N., Laplanche, J., Mouren, M., Launay, J., & Leboyer, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300752 · Cited by 37
Dopamine D2 agonist priming in intact and dopamine-lesioned rats
Kostrzewa, R. M., Kostrzewa, J. P., Nowak, P. G., Kostrzewa, R. A., & Brus, R. (2004) · Neurotoxicity Research · doi:10.1007/bf03033281 · Cited by 37
Gurpegui, M., Martínez-Ortega, J. M., Jurado, D., Aguilar, M. C., Díaz, F. J., & de León, J. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.10.002 · Cited by 37
Cannon, T. D., van Erp, T. G. M., & Glahn, D. C. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00362-0 · Cited by 37
Metabolism and biochemical effects of nicotine for primary care providers
Metz, C. N., Gregersen, P. K., & Malhotra, A. K. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.06.004 · Cited by 37
Nicotine-evoked nitric oxide release in the rat hippocampal slice
Smith, D. A., Hoffman, A. F., David, D., Adams, C. E., & Gerhardt, G. A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00725-3 · Cited by 37
Self-citationRichard, A., Scheffer, I. E., & Wilson, S. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.036 · Cited by 37
Smoking cue reactivity in schizophrenia: Effects of a nicotinic receptor antagonist
Fonder, M. A., Sacco, K. A., Termine, A., Boland, B. S., Seyal, A. A., Dudas, M. M., Vessicchio, J. C., & George, T. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.027 · Cited by 36
Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data
Boutros, N. N., Gelernter, J. E., Gooding, D. C., Cubells, J. F., Young, A., Krystal, J. H., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01237-9 · Cited by 36
Díaz, F. J., Velásquez, D. M., Susce, M. T., & de León, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.004 · Cited by 36
Chaperoning α7 neuronal nicotinic acetylcholine receptors.
Vallés, A. S., & Barrantes, F. (2012) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2011.10.012 · Cited by 35
Imaging genetics of schizophrenia in the post-GWAS era
Arslan, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.018 · Cited by 38
Association of α4β2 nicotinic receptor and heavy smoking in schizophrenia
Voineskos, S. H., Luca, V. D., Mensah, A. K., Vincent, J. B., Potapova, N., & Kennedy, J. L. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0740 · Cited by 37
Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues
Faraone, S. V., Brown, C. H., Glatt, S. J., & Tsuang, M. T. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700604 · Cited by 36
Kéri, S., Beniczky, S., & Kelemen, O. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050723 · Cited by 35
Escamilla, M., Hare, E., Dassori, A. M., Peralta, J. M., Ontiveros, A., Nicolini, H., Raventós, H., Medina, R., Mendoza, R., Jerez, A., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040612 · Cited by 35
Lascio, S. D., Fornasari, D., & Benfante, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073463 · Cited by 35
Altered hippocampal circuit function in C3H α7 null mutant heterozygous mice
Adams, C. E., Yonchek, J. C., Zheng, L., Collins, A. C., & Stevens, K. E. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.007 · Cited by 35
Self-citationChen, X., Li, C., Smith, R. C., Xiao, Z., & Wang, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.009 · Cited by 35
Duffy, Á., Fitzgerald, M. L., Chan, J., Robinson, D. C., Milner, T. A., Mackie, K., & Pickel, V. M. (2011) · Synapse · doi:10.1002/syn.20977 · Cited by 35
Spielewoy, C., & Markou, A. (2004) · Behavior Genetics · doi:10.1023/b:bege.0000017878.75206.fd · Cited by 35
Stevens, K. E., Kem, W. R., & Freedman, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00200-0 · Cited by 35
Self-citationCan biological markers identify endophenotypes predisposing to schizophrenia?
Wickham, H., & Murray, R. M. (1997) · International Review of Psychiatry · doi:10.1080/09540269775222 · Cited by 35
Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder
Radant, A. D., Tsuang, D. W., Peskind, E. R., McFall, M., & Raskind, W. H. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00252-9 · Cited by 35
Selective 5HT3 antagonists and sensory processing: a systematic review
Tsitsipa, E., Rogers, J. P., Casalotti, S., Belessiotis‐Richards, C., Zubko, O., Weil, R. S., Howard, R. J., Bisby, J. A., & Reeves, S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01255-4 · Cited by 34
Feuerbach, D., Pezous, N., Weiss, M., Shakeri-Nejad, K., Lingenhoehl, K., Hoyer, D., Hurth, K., Bilbe, G., Pryce, C., McAllister, K., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13001 · Cited by 32
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
